Palisade Bio Inc (PALI)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
252,692,000
EV to revenue ratio (TTM)
296.92
EV to ebitda
0.571
Financial Performance
Revenue (TTM)
500,000
Gross profit (TTM)
500,000
EBITDA
-35,346,500
Profitability
Operating margin (TTM)
-2,340.00%
Profit margin
0.00%
Return on assets (TTM)
-33.00%
Return on equity (TTM)
-51.40%
Per Share Metrics
Revenue per share (TTM)
0
EPS
0.65
Diluted EPS (TTM)
0.65
Book value
0.7
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
2.231
Trailing P/E
2.231
Forward P/E
PEG ratio
Price to sales ratio (TTM)
505.38
Price to book ratio (TTM)
2.312
Growth
Quarterly earnings growth (YoY)
0.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
1
Buy
7
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.547